Schroth Exercises for Degenerative Scoliosis
(ADSET Trial)
Trial Summary
What is the purpose of this trial?
Adult degenerative scoliosis is the most common spine deformity in adults. Patients present a lateral curvature of the spine and vertebra rotation. Curves meeting indications for treatment affect 24% of the aging adult population. Adult scoliosis causes pain, curve progression, and cosmetic deformity affecting quality of life and function. Pain affects 90% of patients with AS. Other than surgery for severe cases and pain medication, very little non-operative treatments have been investigated. Scoliosis-specific exercises have shown promise in a single study in adults and in an Alberta adolescent study. The goal of this pilot randomized controlled trial on the effect of Schroth exercises in adults with degenerative scoliosis compared to observation is to determine the feasibility of conducting a larger study. This study will help plan and secure funding for a larger study by examining the ability to recruit enough eligible participants, whether patients can follow the prescribed program session attendance and complete the home exercises prescribed. The early estimate the effects of the exercises on pain, quality of life, disability, deformity and posture measurements will help determine the potential of this approach and the likely success of a larger RCT. This study addresses a need of adults with degenerative scoliosis who do not meet surgical indications but still experience pain and disability by exploring a promising exercise approach.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It might be best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Schroth exercises for degenerative scoliosis?
Research shows that Schroth exercises, which are specific exercises for scoliosis, have been effective in reducing the progression of idiopathic scoliosis (a type of scoliosis with no known cause) in adolescents. These exercises help improve the spine's curve, reduce trunk rotation, and enhance quality of life, suggesting they may also be beneficial for degenerative scoliosis.12345
Is the Schroth method safe for humans?
How is the Schroth exercise treatment unique for degenerative scoliosis?
The Schroth exercise treatment is unique because it focuses on three-dimensional correction of the spine using specific exercises that combine sensorimotor, postural, and corrective breathing techniques, which are tailored to the individual's curve pattern. This approach is different from other treatments that may not address the three-dimensional aspect of scoliosis or incorporate such a comprehensive exercise regimen.12578
Research Team
Eric Parent, PT PhD
Principal Investigator
University of Alberta
Eligibility Criteria
This trial is for adults over 50 with degenerative scoliosis, experiencing pain and having a spinal curve between 15°-45°. It's not for those who've had recent injections, surgery, or have conditions like fractures, cancer, severe heart issues, or weak bones.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants in the Schroth exercise group will attend 5 individual sessions to learn exercises and participate in weekly group classes for 3 months.
Control
Participants in the control group will be under observation without treatment or with previously prescribed pain medication for 3 months.
Follow-up
Participants are monitored for longer-term effects 3 months after the exercise program.
Treatment Details
Interventions
- Schroth exercises (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alberta
Lead Sponsor
Bill Flanagan
University of Alberta
Chief Executive Officer since 2020
LLB from University of Toronto, LLM from Columbia University
Dr. Verna Yiu
University of Alberta
Chief Medical Officer since 2012
MD from University of Alberta, Fellowship in Pediatric Nephrology at Harvard University